GS MedTech Funding Tracker – Tissium, CroíValve, and more

GS Funding Tracker
Commercial expansion, clinical validation, and next-generation technologies defined this week's MedTech funding activity. Investors continued to back innovation, with funding spanning surgical robotics, cardiovascular care, ultrasound therapies, AI, and home diagnostics. Here's who raised...

GS MedTech Funding Tracker – Tissium, CroíValve, and more

GS Funding Tracker
Commercial expansion, clinical validation, and next-generation technologies defined this week's MedTech funding activity. Investors continued to back innovation, with funding spanning surgical robotics, cardiovascular...

Coherence Neuro begins first clinical study for BCI

Clinical Trials
Coherence Neuro has initiated its first clinical study of the investigational Cipher brain-computer interface (BCI), marking its transition into human testing. The study, led by...

Pulsenmore announces pricing of $7.5M Private Placement

Funding
Pulsenmore Ltd. has announced a $7.5 million private placement with a single healthcare-focused institutional investor to support the next phase of its commercial growth. The...

Carvolix secures new €10M tranche, bringing total financing to €20M

Funding
Carvolix has raised an additional €10 million tranche, bringing total funding under its €30 million financing programme to €20 million. The new capital reflects...

Get Weekly Newsletter

[hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

Finance

Funding

Clinical Trials

Coherence Neuro begins first clinical study for BCI

Coherence Neuro has initiated its first clinical study of the investigational Cipher brain-computer interface (BCI), marking its transition into human testing. The study, led by...

Imperative Care reports SYMPHONY-PE trial data for pulmonary embolism

Imperative Care has reported results from a post-hoc analysis of the SYMPHONY-PE trial, evaluating the impact of early mechanical thrombectomy in patients with intermediate-risk...

VahatiCor enrolls first U.S. patient in SERRA-I clinical study of A-FLUX Reducer System

VahatiCor has enrolled the first U.S. patient in its SERRA-I early feasibility study, evaluating the investigational A-FLUX Reducer System® for patients with coronary microvascular...

Raydiant Oximetry completes enrollment of First 15 Patients in IDE Pilot Study

Raydiant Oximetry has completed enrollment and data collection for the first 15 patients in its FDA-approved IDE pilot study at LSU Health Shreveport, advancing...

Innovation

Regulatory Approvals

GS MedTech Funding Tracker – Tissium, CroíValve, and more

Commercial expansion, clinical validation, and next-generation technologies defined this week's MedTech funding activity. Investors continued to back innovation, with funding spanning surgical robotics, cardiovascular...

Coherence Neuro begins first clinical study for BCI

Coherence Neuro has initiated its first clinical study of the investigational Cipher brain-computer interface (BCI), marking its transition into human testing. The study, led by...

Pulsenmore announces pricing of $7.5M Private Placement

Pulsenmore Ltd. has announced a $7.5 million private placement with a single healthcare-focused institutional investor to support the next phase of its commercial growth. The...

Carvolix secures new €10M tranche, bringing total financing to €20M

Carvolix has raised an additional €10 million tranche, bringing total funding under its €30 million financing programme to €20 million. The new capital reflects...

M&A

Archives

Latest articles

Load more

Popular categories

Funding1163Regulatory Approvals1032Innovation656Clinical Trials530Mergers & Acquisitions511GS Funding Tracker55